Correlation Between Exelixis and Iovance Biotherapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Exelixis and Iovance Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Iovance Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Iovance Biotherapeutics, you can compare the effects of market volatilities on Exelixis and Iovance Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Iovance Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Iovance Biotherapeutics.

Diversification Opportunities for Exelixis and Iovance Biotherapeutics

-0.12
  Correlation Coefficient

Good diversification

The 3 months correlation between Exelixis and Iovance is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Iovance Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iovance Biotherapeutics and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Iovance Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iovance Biotherapeutics has no effect on the direction of Exelixis i.e., Exelixis and Iovance Biotherapeutics go up and down completely randomly.

Pair Corralation between Exelixis and Iovance Biotherapeutics

Given the investment horizon of 90 days Exelixis is expected to generate 0.59 times more return on investment than Iovance Biotherapeutics. However, Exelixis is 1.69 times less risky than Iovance Biotherapeutics. It trades about 0.4 of its potential returns per unit of risk. Iovance Biotherapeutics is currently generating about -0.18 per unit of risk. If you would invest  2,787  in Exelixis on August 26, 2024 and sell it today you would earn a total of  774.00  from holding Exelixis or generate 27.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Exelixis  vs.  Iovance Biotherapeutics

 Performance 
       Timeline  
Exelixis 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.
Iovance Biotherapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Iovance Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Exelixis and Iovance Biotherapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Exelixis and Iovance Biotherapeutics

The main advantage of trading using opposite Exelixis and Iovance Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Iovance Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iovance Biotherapeutics will offset losses from the drop in Iovance Biotherapeutics' long position.
The idea behind Exelixis and Iovance Biotherapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing